Latest Posts

The use of genetic information outside of the health context can create some concerns regarding the possibility that it may negatively affect someone based on their genetic profile, a phenomenon referred to as genetic discrimination. The Genetic Discrimination Observatory (GDO) is a unique communication platform created to help prevent genetic discrimination. The GDO is currently holding…

The foundational step of this major project is a pilot program on rare diseases. Genome Canada is encouraging the submission of projects to the Genomic Applications Partnership Program (GAPP). The projects must translate research into clinical implementation with the goal of having genome sequencing offered as a clinical genetic test within an established diagnostic and…

Génome Québec is proud to take part in this initiative of the Terry Fox Research Institute, which will generate new advances in precision medicine. Research done by the participating institutions will seek to improve treatments for 18,000 cancer patients treated annually in Québec, particularly with the development of immunotherapy. “Génome Québec salutes this initiative that…

Discovery will aid diagnosis and development of treatments. Scientists at the Montreal Neurological Institute and Hospital (The Neuro) and McGill University have identified novel genes associated with a specific form of schizophrenia. Schizophrenia is a major psychiatric illness affecting one per cent of the population worldwide. Patients suffering from schizophrenia present delusions, hallucinations, abnormal behavior,…

Genome Canada, in partnership with Agriculture and Agri-Food Canada, launches the 2018 Large-Scale Applied Research Project Competition: Genomics Solutions for Agriculture, Agri-food, Fisheries and Aquaculture. This competition aims to finance projects that will propose genomic solutions to advance the sustainability, productive capacity and competitiveness of these key sectors, and thereby contribute to the Canadian bioeconomy…

The Program committee solicits papers describing significant and innovative research contributions to the field of personalized medicine and health care. ICPHC 2018 will be a great opportunity to showcase all the research projects and achievements that will help governments, researchers, academics, clinicians and all professionals to answer the challenges they are facing in the search for…

Pilot initiative for rare diseases to lay the foundation for the adoption of precision health across Canada. Genomics-based precision health promises to improve patient health and increase efficiency of health-care delivery. Today, Genome Canada launched a national initiative for the clinical implementation of precision health, focusing on a rare disease pilot program as a foundational…

On May 17 in Montréal, Concordia University is organizing an event to bring together companies and academics working on biomedical research with the objective of creating solid and mutually beneficial research collaboration partnerships. This event is directed to companies and researchers working in the areas of: Disease mechanisms Biomarkers and diagnostics Drug discovery Drug delivery Biomedical…

Discover in this video the moving testmonies of patients sharing their story and commending the remarkable work of four scientists that devote their lives to improve healthcare quality in Québec.            To learn more about the projects of these researchers, click here. To learn more about the major investments recently announced…

Our greater knowledge of the human genome is helping health professionals better understand a growing number of diseases leading to more effective treatments. Progress made in the field of precision medicine will transform patient care through better prevention, more accurate diagnoses and improved therapies. The changes will be beneficial for the health of all Quebecers and…